Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett E Skolnick

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Stroke|December 5, 2009
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trialMichael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
Neurosurgery|October 14, 2006
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VIIThorsten Steiner, Michael N Diringer, Dietmar Schneider, et al.
The New England Journal of Medicine|May 16, 2008
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhageStephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
American Journal of Hematology|April 6, 2017
The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crisesEdward Gomperts, John D Belcher, Leo E Otterbein, et al.
Stroke|January 20, 2009
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?Stephan A Mayer, Stephen M Davis, Brett E Skolnick, et al.
Stroke|February 10, 2007
Determinants of intracerebral hemorrhage growth: an exploratory analysisJoseph P Broderick, Michael N Diringer, Michael D Hill, et al.
The New England Journal of Medicine|December 11, 2014
A clinical trial of progesterone for severe traumatic brain injuryBrett E Skolnick, Andrew I Maas, Raj K Narayan, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 17, 2007
Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhageMichael N Diringer, Jean-Marc Ferran, Joseph Broderick, et al.
Journal of Neurosurgery|May 7, 2002
Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safetyTanya Simuni, Jurg L Jaggi, Heather Mulholland, et al.
Stroke|March 17, 2009
Density and shape as CT predictors of intracerebral hemorrhage growthChristen D Barras, Brian M Tress, Soren Christensen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Stroke|December 5, 2009
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trialMichael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
Neurosurgery|October 14, 2006
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VIIThorsten Steiner, Michael N Diringer, Dietmar Schneider, et al.
The New England Journal of Medicine|May 16, 2008
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhageStephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
American Journal of Hematology|April 6, 2017
The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crisesEdward Gomperts, John D Belcher, Leo E Otterbein, et al.
Stroke|January 20, 2009
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?Stephan A Mayer, Stephen M Davis, Brett E Skolnick, et al.
Stroke|February 10, 2007
Determinants of intracerebral hemorrhage growth: an exploratory analysisJoseph P Broderick, Michael N Diringer, Michael D Hill, et al.
The New England Journal of Medicine|December 11, 2014
A clinical trial of progesterone for severe traumatic brain injuryBrett E Skolnick, Andrew I Maas, Raj K Narayan, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 17, 2007
Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhageMichael N Diringer, Jean-Marc Ferran, Joseph Broderick, et al.
Journal of Neurosurgery|May 7, 2002
Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safetyTanya Simuni, Jurg L Jaggi, Heather Mulholland, et al.
Stroke|March 17, 2009
Density and shape as CT predictors of intracerebral hemorrhage growthChristen D Barras, Brian M Tress, Soren Christensen, et al.
Pageof 3